HLA-C and neoplasm: These T cells equipped with T-cell receptors (TCRs) on their surfaces (7, 8), act like specialized “scanners.” They specifically recognize abnormal antigen peptides presented by major histocompatibility complex (MHC) molecules on tumor cells (9).